Cargando…
Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response
PURPOSE: Heme depletion, through inhibition of ferrochelatase (FECH), blocks retinal and choroidal neovascularization. Both pharmacologic FECH inhibition and a partial loss-of-function Fech mutation (Fech(m1Pas)) are associated with decreased neovascularization. However, the ocular physiology of Fec...
Autores principales: | Sardar Pasha, S. P. B., Shetty, Trupti, Lambert-Cheatham, Nathan A., Sishtla, Kamakshi, Mathew, Deepa, Muniyandi, Anbukkarasi, Patwari, Neeta, Bhatwadekar, Ashay D., Corson, Timothy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910629/ https://www.ncbi.nlm.nih.gov/pubmed/33620374 http://dx.doi.org/10.1167/iovs.62.2.36 |
Ejemplares similares
-
Ferrochelatase is a therapeutic target for ocular neovascularization
por: Basavarajappa, Halesha D, et al.
Publicado: (2017) -
An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images
por: Jensen, Nathan R., et al.
Publicado: (2022) -
PRMT5 is a therapeutic target in choroidal neovascularization
por: Muniyandi, Anbukkarasi, et al.
Publicado: (2023) -
Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
por: Park, Bomina, et al.
Publicado: (2022) -
Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction
por: Shetty, Trupti, et al.
Publicado: (2020)